Literature DB >> 31280219

Immunohistochemical Expression of CD133 and LGR5 in Ulcerative Colitis-associated Colorectal Cancer and Dysplasia.

Shinsuke Kazama1,2, Junko Kishikawa2, Toshiaki Tanaka2, Keisuke Hata2, Kazushige Kawai2, Hiroaki Nozawa2, Soichiro Ishihara2.   

Abstract

BACKGROUND/AIM: Cluster of differentiation 133 (CD133) and leu cine-rich orphan G-protein-coupled receptor 5 (LGR5) are the most putative stem cell markers for colorectal cancer (CRC), and are associated with poor prognosis of patients with CRC. However, the role of CD133 and LGR5 in the inflammation-dysplasia-carcinoma sequence has not been fully elucidated. We examined the expression of CD133 and LGR5 in ulcerative colitis-associated CRC (UC-CRC; n=20) and UC-associated colorectal dysplasia (n=16) by immunohistochemistry.
RESULTS: The rate of CD133-positive cases in UC-CRC was significantly higher than that in dysplasia (p=0.026), but that of LGR5 expression was not. Moreover, LGR5 expression was significantly positively associated with p53 expression (p=0.03), whereas CD133 expression positively correlated with p53 expression, but not significantly (p=0.10).
CONCLUSION: CD133 may play an important role in tumor development in the context of the inflammation-dysplasia-carcinoma sequence. LGR5-positive cancer stem cells may play a critical role in the development of UC-CRC, particularly upon loss of p53 function. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CD133; LGR5; immunohistochemistry; p53; ulcerative colitis-associated colorectal cancer

Year:  2019        PMID: 31280219      PMCID: PMC6689354          DOI: 10.21873/invivo.11600

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  4 in total

1.  A nine-gene signature to improve prognosis prediction of colon carcinoma.

Authors:  Jinlai Zhao; Yigang Wang; Jianchao Gao; Yang Wang; Xuan Zhong; Xiaotang Wu; Hua Li
Journal:  Cell Cycle       Date:  2021-05-14       Impact factor: 4.534

2.  Most colitis associated carcinomas lack expression of LGR5: a preliminary study with implications for unique pathways of carcinogenesis compared to sporadic colorectal carcinoma.

Authors:  Mai Iwaya; Hiroyoshi Ota; Tomoyuki Nakajima; Takeshi Uehara; Robert Riddell; James Conner
Journal:  BMC Cancer       Date:  2021-02-04       Impact factor: 4.430

3.  Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer.

Authors:  Davide Brocco; Pasquale Simeone; Davide Buca; Pietro Di Marino; Michele De Tursi; Antonino Grassadonia; Laura De Lellis; Maria Teresa Martino; Serena Veschi; Manuela Iezzi; Simone De Fabritiis; Marco Marchisio; Sebastiano Miscia; Alessandro Cama; Paola Lanuti; Nicola Tinari
Journal:  Cancers (Basel)       Date:  2022-03-07       Impact factor: 6.639

4.  Persistence of Lgr5+ colonic epithelial stem cells in mouse models of inflammatory bowel disease.

Authors:  Nandini Girish; Cambrian Y Liu; Safina Gadeock; Marie L Gomez; Ying Huang; Zohreh Sharifkhodaei; M Kay Washington; D Brent Polk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-07-14       Impact factor: 4.871

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.